NextCure (NXTC) Research & Development (2018 - 2026)
NextCure (NXTC) recorded Research & Development of $7.43 million in Q2 2026, down 69.2% from $24.09 million a year earlier but up 8.6% from the prior quarter.
Powered by 
Analysis
NextCure (NXTC) Research & Development (2018 - 2026) Analysis & Trends
On a TTM basis, NextCure's Research & Development came in at $27.2 million as of Jun 30, 2026, down 45.2% year-over-year; for FY2025, it was $44.92 million, up 8.3% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $41.49 million in FY2024 (-13.4%), $47.93 million in FY2023 (-11.6%), $54.2 million in FY2022 (+8.0%) and $50.19 million in FY2021 (+7.8%).
- Quarterly Research & Development has ranged from $6.14 million in Q3 2025 to $24.09 million in Q2 2025 over the past five years.
- On a year-over-year basis, Research & Development has declined for four consecutive quarters, with an average decline of 14.8% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 94.0% in Q2 2025, against a decline of 69.2% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.83 million (Q1 2026), $6.8 million (Q4 2025) and $6.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.96 Bn | 1,103.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 616.51 Bn | 535.04 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.10 Bn | 474.21 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.09 Bn | 321.47 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.10 Bn | 262.09 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.72 Bn | 235.40 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.73 Bn | 191.13 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 2.81 Bn |
| 10 | NextCure | 29.36 Mn | -91.40 Mn | - | 7.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.43 Mn |
| Mar 31, 2026 | 6.83 Mn |
| Dec 31, 2025 | 6.80 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 24.09 Mn |
| Mar 31, 2025 | 7.90 Mn |
| Dec 31, 2024 | 8.90 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Jun 30, 2024 | 12.42 Mn |
| Mar 31, 2024 | 11.40 Mn |
| Dec 31, 2023 | 11.83 Mn |
| Sep 30, 2023 | 11.01 Mn |
| Jun 30, 2023 | 13.45 Mn |
| Mar 31, 2023 | 11.65 Mn |
| Dec 31, 2022 | 12.82 Mn |
| Sep 30, 2022 | 13.53 Mn |
| Jun 30, 2022 | 12.83 Mn |
| Mar 31, 2022 | 15.02 Mn |
| Dec 31, 2021 | 12.26 Mn |
| Sep 30, 2021 | 13.60 Mn |
API Access
NextCure Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();